日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hypobaric hypoxia can lead to an increase in lung dendritic cells and promote T-cell immunosuppression, thereby preventing the excessive progression of high-altitude pulmonary edema

低压低氧可导致肺树突状细胞增多并促进T细胞免疫抑制,从而防止高原肺水肿过度进展。

Wei, Xuemei; Shi, Wenhui; Dong, Xiang; Kong, Weina; Dong, Lingling; Zhang, Ling; Maimaitituerxun, Aziguli; Hou, Congying; Li, Dewei; Liu, Jiangwei; Ma, Xiumin

TFE3 fusion proteins drive TFE3 rearranged renal cell carcinoma progression via PGC-1α-mediated fatty acid oxidation.

TFE3 融合蛋白通过 PGC-1α 介导的脂肪酸氧化驱动 TFE3 重排肾细胞癌的进展。

Feng Fan, Xu Yanhao, Deng Zhenggen, Dong Xiang, Chen Guijuan, Ma Wenliang, Li Dongmei, Gan Weidong

Multimodal Phase-Space Dynamics Fusion for Robust Ischemia Screening: An Edge-AI Paradigm with SERF Magnetocardiography

用于稳健缺血筛查的多模态相空间动力学融合:基于SERF磁心动图的边缘人工智能范式

Li, Keyi; Zhou, Xiangyang; Jia, Yifan; Wang, Ruizhe; Cao, Yidi; Pang, Jiaojiao; Shang, Rui; Zhang, Yadan; Cui, Yangyang; Xu, Dong; Xiang, Min

Generating high-quality porcine iPSCs with the new medium cocktail LACID

利用新型培养基混合物 LACID 生成高质量的猪诱导多能干细胞

Shi, Bingbo; Li, Jiajun; Wang, Xiaomin; Liu, Dong; Xiang, Jinzhu; Wang, Hanning; Xu, Changjiang; Zou, Xinle; Wang, Zhuangfei; Huang, Tao; Min, Qiankun; Wang, Kaipeng; Yang, Yihang; Li, Junyang; Wang, Bo; Zhao, Chengchen; Pei, Duanqing

The p53 R181C mutation accumulates through impaired deacetylation by Sirt1 and facilitates tumor development.

p53 R181C 突变通过 Sirt1 的去乙酰化作用受损而积累,并促进肿瘤发展。

Wang Erli, Cao Liangzi, Guo Wendong, Dong Xiang, Zhang Wanying, Zhang Xiaowen, Wang Zhuo, Chen Xia, Li Aicun, Zou Yu, Li Shikun, Chen Kedian, Su Han, Cao Sunrun, Du Ning, Wang Pingyuan, Hwang Paul M, Liu Xiangsheng, Song Xiaoyu, Xu Hongde, Liu Jingwei, Cao Liu

Chaotic Dynamics Analysis of Magnetocardiography Signals for Early Detection of Myocardial Ischemia

利用混沌动力学分析磁心动图信号早期检测心肌缺血

Li, Keyi; Zhou, Xiangyang; Liu, Yuchen; Pang, Jiaojiao; Shang, Rui; Zhang, Yadan; Cui, Yangyang; Xu, Dong; Xiang, Min

Toward personalized prediction: a multicenter machine learning model for omalizumab response duration in moderate-to-severe perennial allergic rhinitis

迈向个性化预测:用于预测中重度常年性过敏性鼻炎患者奥马珠单抗疗效持续时间的多中心机器学习模型

Miao, Ziqi; Dong, Lin; Liu, Jin; Li, Le; Dong, Xiang; Zhang, Shuchen; Zhu, Rongfei; Deng, Yuqin

Respiratory ventilation modes in selective ophthalmic arterial chemotherapy for pediatric retinoblastoma under general anesthesia

在全身麻醉下对儿童视网膜母细胞瘤进行选择性眼动脉化疗的呼吸通气模式

Wang, Yuxing; Dong, Xiang; Gao, Weiling; Dong, Jiegang; Wang, Xu; Chen, Jie; Jiang, Hong

Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial

新辅助替雷利珠单抗(一种PD-1抑制剂)联合白蛋白紫杉醇序贯表柔比星/环磷酰胺治疗三阴性乳腺癌的疗效、安全性及探索性分析:一项II期TREND试验

Qiang Zhang # ,Mozhi Wang # ,Yumeng Li ,Hengjun Zhang ,Yusong Wang ,Xiuyun Chen ,Litong Yao ,Mingke Cui ,Haoran Dong ,Xiang Li ,Jian Liu ,Bo Zhu ,Yingying Xu

Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial

高危N2至N3期鼻咽癌患者诱导化疗与辅助放化疗的比较:一项3期随机临床试验

Guo, Shan-Shan; Li, Xiao-Yun; Liu, Li-Ting; Jia, Guo-Dong; Liu, Sai-Lan; Sun, Xue-Song; Luo, Dong-Hua; Yang, Jin-Hao; Xie, Si-Yi; Li, Yi-Fu; Lv, Xing; Xiang, Yan-Qun; Xia, Wei-Xiong; Sun, Rui; Liu, Qing; Li, Ji-Bin; Wang, Pan; Yang, Qi; Wang, Lin; Wen, Dong-Xiang; Jin, Jing; Lin, Jie-Yi; Mo, Hao-Yuan; Guo, Ling; Zhao, Chong; Guo, Xiang; Chen, Qiu-Yan; Tang, Lin-Quan; Mai, Hai-Qiang